Acumen Pharmaceuticals, Inc. ABOS

Set alert

Price alert · ABOS

All alert types
0.21 USD -2.08 -90.83%

At close · Oct 30

0.22 +0.01 +5.24%

After hours · Oct 30, 7:59 PM ET

Bid
0.22 × 2
Ask
0.22 × 2
0.21 Day range 0.352
0.2101 52-week range 3.37
YTD
-90.04%
1 year
-90.54%
Open
0.3394
Prev close
2.29
Mkt cap
15.20M
Vol
68.11M
Avg vol
520.26K
EPS
-1.55
P/E
0.00
Div yield
0.00%
More statistics
Low
0.21
High
0.352
Forward P/E
-1.17
Beta
0.04
Short ratio
6.61
Inst. own
78.46%
Dividend
0.00
Ex-div date
Earnings
Aug 13, 2024
50-d avg
2.48
200-d avg
2.89
1y target
10.80

5D chart

Chart tools
Interval

Signals (78)
NameTimeAgo
SMA: BearishOct 30, 3:55 PM2 days ago
SMA: BullishOct 30, 3:50 PM2 days ago
RSI: OversoldOct 30, 3:15 PM2 days ago
SMA: BearishOct 30, 2:40 PM2 days ago
SMA: BullishOct 30, 2:35 PM2 days ago
SMA: BearishOct 30, 12:45 PM2 days ago
SMA: BullishOct 30, 12:35 PM2 days ago
SMA: BearishOct 30, 12:30 PM2 days ago
SMA: BullishOct 30, 12:25 PM2 days ago
SMA: BearishOct 30, 11:50 AM2 days ago
SMA: BullishOct 30, 11:45 AM2 days ago
SMA: BearishOct 30, 11:40 AM2 days ago
SMA: BullishOct 30, 11:35 AM2 days ago
MACD: Buy SignalOct 30, 10:40 AM2 days ago
RSI: OversoldOct 30, 9:30 AM2 days ago
RSI: OversoldOct 29, 3:50 PM3 days ago
MACD: Sell SignalOct 29, 3:20 PM3 days ago
RSI: OversoldOct 29, 3:20 PM3 days ago
MACD: Buy SignalOct 29, 3:15 PM3 days ago
MACD: Sell SignalOct 29, 3:00 PM3 days ago
RSI: OversoldOct 29, 3:00 PM3 days ago
MACD: Buy SignalOct 29, 2:45 PM3 days ago
MACD: Sell SignalOct 29, 2:25 PM3 days ago
RSI: OversoldOct 29, 2:25 PM3 days ago
MACD: Buy SignalOct 29, 2:15 PM3 days ago
SMA: BearishOct 29, 12:10 PM3 days ago
MACD: Sell SignalOct 29, 12:00 PM3 days ago
SMA: BullishOct 29, 10:55 AM3 days ago
SMA: BullishOct 29, 10:55 AM3 days ago
MACD: Buy SignalOct 29, 10:55 AM3 days ago
MACD: Sell SignalOct 29, 10:35 AM3 days ago
SMA: BullishOct 29, 10:15 AM3 days ago
SMA: BearishOct 29, 10:05 AM3 days ago
MACD: Buy SignalOct 29, 10:00 AM3 days ago
SMA: BullishOct 29, 9:55 AM3 days ago
SMA: BullishOct 29, 9:35 AM3 days ago
MACD: Sell SignalOct 28, 3:00 PM4 days ago
RSI: OverboughtOct 28, 2:00 PM4 days ago
MACD: Buy SignalOct 28, 1:50 PM4 days ago
MACD: Sell SignalOct 28, 1:40 PM4 days ago
MACD: Buy SignalOct 28, 1:15 PM4 days ago
MACD: Sell SignalOct 28, 12:55 PM4 days ago
MACD: Buy SignalOct 28, 12:40 PM4 days ago
SMA: BearishOct 28, 12:20 PM4 days ago
SMA: BullishOct 28, 11:35 AM4 days ago
SMA: BearishOct 28, 11:00 AM4 days ago
MACD: Sell SignalOct 28, 11:00 AM4 days ago
SMA: BullishOct 28, 10:55 AM4 days ago
SMA: BearishOct 28, 10:50 AM4 days ago
MACD: Buy SignalOct 28, 9:55 AM4 days ago
SMA: BullishOct 28, 9:35 AM4 days ago
SMA: BullishOct 27, 3:55 PM5 days ago
SMA: BearishOct 27, 3:50 PM5 days ago
MACD: Sell SignalOct 27, 3:30 PM5 days ago
RSI: OverboughtOct 27, 2:50 PM5 days ago
SMA: BullishOct 27, 1:55 PM5 days ago
SMA: BullishOct 27, 1:55 PM5 days ago
SMA: BearishOct 27, 1:50 PM5 days ago
SMA: BearishOct 27, 12:45 PM5 days ago
MACD: Buy SignalOct 27, 12:10 PM5 days ago
SMA: BullishOct 27, 12:05 PM5 days ago
MACD: Sell SignalOct 27, 11:25 AM5 days ago
SMA: BearishOct 27, 11:10 AM5 days ago
SMA: BearishOct 27, 11:00 AM5 days ago
SMA: BullishOct 27, 10:45 AM5 days ago
MACD: Buy SignalOct 27, 10:40 AM5 days ago
SMA: BullishOct 27, 10:30 AM5 days ago
RSI: OversoldOct 27, 10:10 AM5 days ago
SMA: BearishOct 26, 3:40 PM6 days ago
RSI: OverboughtOct 26, 3:30 PM6 days ago
MACD: Sell SignalOct 26, 3:25 PM6 days ago
RSI: OverboughtOct 26, 3:05 PM6 days ago
RSI: OverboughtOct 26, 2:40 PM6 days ago
RSI: OverboughtOct 26, 1:45 PM6 days ago
SMA: BullishOct 26, 11:50 AM6 days ago
SMA: BearishOct 26, 11:45 AM6 days ago
SMA: BearishOct 26, 11:10 AM6 days ago
SMA: BearishOct 26, 10:20 AM6 days ago

Financial health

Altman Z-Score

-11.70 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C-1 / 5 overall

  • DCF 2
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 2

Valuation

P/E -1.1×
FY 2019: -101×FY 2020: -77.3×FY 2021: -2.6×FY 2022: -5.1×FY 2023: -3.6×FY 2024: -1.0×FY 2025: -1.1×
FY 2019 5y median -2.6× FY 2025
P/S 0.0×
FY 2019: 339×FY 2020: 401×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2019 5y median 0.0× FY 2025
P/B 1.8×
FY 2019: -50.4×FY 2020: -31.0×FY 2021: 1.1×FY 2022: 1.2×FY 2023: 0.7×FY 2024: 0.6×FY 2025: 1.8×
FY 2019 5y median 1.1× FY 2025
P/FCF -1.1×
FY 2019: -84.5×FY 2020: -77.3×FY 2021: -14.4×FY 2022: -6.2×FY 2023: -4.3×FY 2024: -1.2×FY 2025: -1.1×
FY 2019 5y median -4.3× FY 2025
EV/EBITDA -0.9×
FY 2019: 0.0×FY 2020: -67.3×FY 2021: -1.4×FY 2022: -2.1×FY 2023: -2.9×FY 2024: -1.0×FY 2025: -0.9×
FY 2019 5y median -1.4× FY 2025
EV/Sales 0.0×
FY 2019: 336×FY 2020: 371×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2019 5y median 0.0× FY 2025
FCF Yield -90.5%
FY 2019: -1.2%FY 2020: -1.3%FY 2021: -7.0%FY 2022: -16.1%FY 2023: -23.1%FY 2024: -83.5%FY 2025: -90.5%
FY 2019 5y median -23.1% FY 2025

Profitability

Gross Margin 0.0%
FY 2019: -405.4%FY 2020: -456.9%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2019: -459.9%FY 2020: -551.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2019: -465.9%FY 2020: -510.1%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 5y median 0.0% FY 2025
ROE -172.3%
FY 2019: 69.2%FY 2020: 39.4%FY 2021: -44.7%FY 2022: -22.7%FY 2023: -19.6%FY 2024: -56.3%FY 2025: -172.3%
FY 2019 5y median -44.7% FY 2025
ROIC -121.7%
FY 2019: -130.5%FY 2020: -20.8%FY 2021: -8.7%FY 2022: -24.0%FY 2023: -20.5%FY 2024: -53.9%FY 2025: -121.7%
FY 2019 5y median -24.0% FY 2025
ROA -98.8%
FY 2019: -108.0%FY 2020: -16.5%FY 2021: -43.7%FY 2022: -21.8%FY 2023: -16.9%FY 2024: -42.8%FY 2025: -98.8%
FY 2019 5y median -42.8% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2019: 0.0%FY 2020: -15.4%FY 2021: -100.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 FY 2025
Operating Income -8.6%
FY 2019: 0.0%FY 2020: -1.4%FY 2021: -147.5%FY 2022: -131.0%FY 2023: -35.2%FY 2024: -86.5%FY 2025: -8.6%
FY 2019 FY 2025
EPS (diluted) -17.0%
FY 2019: 0.0%FY 2020: 3.7%FY 2021: -911.5%FY 2022: 59.7%FY 2023: -1.9%FY 2024: -58.3%FY 2025: -17.0%
FY 2019 FY 2025
Free Cash Flow -34.1%
FY 2019: 0.0%FY 2020: -9.3%FY 2021: -141.6%FY 2022: -96.2%FY 2023: -22.0%FY 2024: -100.1%FY 2025: -34.1%
FY 2019 FY 2025

Financial Health

Current Ratio 4.1×
FY 2019: 5.3×FY 2020: 7.0×FY 2021: 38.6×FY 2022: 23.1×FY 2023: 19.0×FY 2024: 6.5×FY 2025: 4.1×
FY 2019 5y median 19.0× FY 2025
Quick Ratio 4.1×
FY 2019: 5.3×FY 2020: 7.0×FY 2021: 38.6×FY 2022: 23.1×FY 2023: 19.0×FY 2024: 6.5×FY 2025: 4.1×
FY 2019 5y median 19.0× FY 2025
Debt / Equity 0.4×
FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.1×FY 2024: 0.2×FY 2025: 0.4×
FY 2019 5y median 0.1× FY 2025
Net Debt / EBITDA 0.2×
FY 2019: 0.0×FY 2020: 5.5×FY 2021: 1.2×FY 2022: 3.0×FY 2023: 0.7×FY 2024: 0.1×FY 2025: 0.2×
FY 2019 5y median 0.7× FY 2025
Interest Coverage -29.3×
FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: -105×FY 2024: -28.0×FY 2025: -29.3×
FY 2019 5y median -28.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31